Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy

Teratology

Volumn 32, Issue 2, 1985, Pages 321-321

  Milham, Samuel ^a  

^a Dept of Social and Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; THIAMAZOLE;

CHEMICAL TERATOGENESIS; CONGENITAL DISORDER; DRUG EFFICACY; DRUG THERAPY; EDITORIAL; ENDOCRINE SYSTEM; HUMAN; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; SKIN APLASIA; THERAPY;

CARBIMAZOLE; FEMALE; HUMAN; HYPERTHYROIDISM; INFANT, NEWBORN; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; SCALP; TERATOGENS;

EID: 0021930418     PISSN: 00403709     EISSN: 10969926     Source Type: Journal    
DOI: 10.1002/tera.1420320221     Document Type: Letter

References (4)

1. The pharmacological basis of therapeutics
2. Congenital malformation surveillance system based on vital records
3. Maternal methimazole and congenital defects in children
4. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole